| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 06/26/2008 | WO2008077086A1 Aminopyrimidines useful as inhibitors of protein kinases |
| 06/26/2008 | WO2008076883A2 Triazine derivatives and their therapeutical applications |
| 06/26/2008 | WO2008076778A1 4-amino-1h-pyrimidin-2-one based compounds, compositions comprising them, and methods of their use |
| 06/26/2008 | WO2008076754A2 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| 06/26/2008 | WO2008076685A2 Process for the preparation of piperazinyl and diazepanyl benzamide derivatives |
| 06/26/2008 | WO2008076247A2 Nitroderivatives as angiotensin ii receptor antagonists |
| 06/26/2008 | WO2008076246A2 Nitroderivatives as angiotensin ii receptor antagonists |
| 06/26/2008 | WO2008076245A2 Nitroderivatives as angiotensin ii receptor antagonists |
| 06/26/2008 | WO2008076048A1 Indazolyl ester and amide derivatives for the treatment of glucocorticoid receptor mediated disorders |
| 06/26/2008 | WO2008076046A1 Novel 2-amino-5, 5-diaryl-imidazol-4-ones |
| 06/26/2008 | WO2008076045A1 Novel 2-amino- 5-aryl-imidazol-4 -ones |
| 06/26/2008 | WO2008075163A2 An improved process for the preparation of rizatriptan |
| 06/26/2008 | WO2008075073A1 Novel crystalline compound useful as glk activator |
| 06/26/2008 | WO2008075070A1 Sulfonamide derivatives for therapeutic use as fatty acid synthase inhibitors |
| 06/26/2008 | WO2008075019A1 Modulators of cb1 receptors |
| 06/26/2008 | WO2008075012A1 Cb1 receptor modulators |
| 06/26/2008 | WO2008074982A1 Pyrazole derivatives as modulators of cannabinoid receptor |
| 06/26/2008 | WO2008074858A1 Intermediates and process for the production of 5-substituted tricyclic benzimidazoles |
| 06/26/2008 | WO2008074752A2 Indolylmaleimide derivatives as kinase inhibitors |
| 06/26/2008 | WO2008074703A1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives |
| 06/26/2008 | WO2008074515A1 Novel hetaryl-phenylene-diamine pyrimidine as protein kinase inhibitors |
| 06/26/2008 | WO2008074068A1 Substituted quinoline derivatives as antiamyloidogeneic agents |
| 06/26/2008 | WO2008057601A3 Organic compounds |
| 06/26/2008 | WO2007117401A3 Indoles and benzoimidazoles as modulators of the histamine h4 receptor |
| 06/26/2008 | WO2006108791A3 Heterocyclylethylheterocyclylcarboxamide derivatives as fungicides |
| 06/26/2008 | US20080153892 1-(Urea-, thiourea- and cyanoguanidine-methylene)benzyl)imidaoles, treatment of neuronal disorders, especially Alzheimer's disease, Down Syndrome, Parkinson's disease and Huntington's disease |
| 06/26/2008 | US20080153869 2-hydroxy-1H-indol derivatives enzyme inhibitors for preventing or treating inflammation, inflammatory bowel disease, psoriasis, dementia related diseases Alzheimer's Disease, Cognitive Impairment, arthritis, neurodegenerative diseases, amyotrophic lateral sclerosis, Down syndrome, Huntington's Disease |
| 06/26/2008 | US20080153850 Adamantyl Derivates as P2x7 Receptor Antagonists |
| 06/26/2008 | US20080153836 1H-Quinazoline-2,4-Diones |
| 06/26/2008 | US20080153821 Nitrogen-containing 5-membered ring compound |
| 06/26/2008 | US20080153816 Indole Compounds, Method of Preparing Them and Uses Thereof |
| 06/26/2008 | US20080153815 Pinane-substituted pyrimidinediamine derivatives useful as axl inhibitors |
| 06/26/2008 | US20080153812 Novel compounds |
| 06/26/2008 | US20080153810 novel indazole that may be used as melanin concentrating hormone receptor ligands, methods of preparing such compounds, compositions containing such compounds, and methods of using such compounds to treat MCH related disorders. |
| 06/26/2008 | US20080153800 3-{[5-(azetidin-1-ylcarbonyl)pyrazin-2-yl]oxy}-5-[(1-methylethyl)oxy]-N-1H-pyrazol-3-ylbenzamide; glucokinase (GLK or GK) activator; type II diabetes |
| 06/26/2008 | US20080149097 Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disordersB |
| 06/26/2008 | DE102007003036A1 Pyrimidinylpyrazole Pyrimidinylpyrazole |
| 06/26/2008 | CA2673359A1 Cb1 receptor modulators |
| 06/26/2008 | CA2673358A1 Pyrazole derivatives as modulators of cannabinoid receptor |
| 06/26/2008 | CA2673353A1 Aminopyrimidines useful as inhibitors of protein kinases |
| 06/26/2008 | CA2673277A1 Indazolyl ester and amide derivatives for the treatment of glucocorticoid receptor mediated disorders |
| 06/26/2008 | CA2673177A1 Modulators of cb1 receptors |
| 06/26/2008 | CA2672893A1 Triazine derivatives and their therapeutical applications |
| 06/26/2008 | CA2672668A1 4-amino-1h-pyrimidin-2-one-based compounds, compositions comprising them and methods of their use |
| 06/26/2008 | CA2672661A1 Process for the preparation of piperazinyl and diazepanyl benzamide derivatives |
| 06/26/2008 | CA2672521A1 Pyrazole derivatives as protein kinase inhibitors |
| 06/26/2008 | CA2672271A1 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| 06/26/2008 | CA2671673A1 Angiotensin ii receptor antagonists |
| 06/26/2008 | CA2671535A1 Novel crystalline compound useful as glk activator |
| 06/26/2008 | CA2671525A1 Indolylmaleimide derivatives |
| 06/26/2008 | CA2671378A1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives |
| 06/26/2008 | CA2658111A1 Improved process for the preparation of voriconazole |
| 06/25/2008 | EP1935887A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands |
| 06/25/2008 | EP1934203A2 Alpha2c adrenoreceptor agonists |
| 06/25/2008 | EP1934200A1 Tyrosine kinase inhibitors |
| 06/25/2008 | EP1934185A1 Pyrazole compounds that modulate hsp90 activity |
| 06/25/2008 | EP1934174A1 Azetidines as mek inhibitors for the treatment of proliferative diseases |
| 06/25/2008 | EP1933622A2 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof |
| 06/25/2008 | EP1730119B1 Imidazole compounds for the treatment of neurodegenerative disorders |
| 06/25/2008 | EP1606266A4 Chemical compounds |
| 06/25/2008 | EP1603572A4 Lactam-containing cyclic diamines and derivatives as factor xa inhibitors |
| 06/25/2008 | EP1458393B1 Substituted diketopiperazines as oxytocin antagonists |
| 06/25/2008 | CN101208333A Solid forms of 1-(5-(1H-1,2,4-triazol-5-yl)(1H-indazol-3-yl))-3-(2-piperidylethoxy)benzene |
| 06/25/2008 | CN101208331A Quinazoline derivatives as egf and/or erbb2 tyrosine kinase inhibitors |
| 06/25/2008 | CN101208327A New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases |
| 06/25/2008 | CN101208311A Pyrazine -2-carboxamide derivatives as mglur5 antagonists |
| 06/25/2008 | CN101208303A CGRP receptor antagonists |
| 06/25/2008 | CN101208094A Pharmacokinetically improved compounds |
| 06/25/2008 | CN101205555A Schistosoma japonicum resistant medicine action target, medicine sifting method and lead compounds |
| 06/25/2008 | CN100396680C Vla-4 inhibitors |
| 06/25/2008 | CN100396679C Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 06/25/2008 | CN100396670C N-substituted tricyclic 3-aminopyrazoles as PDFG receptor inhibitors, its pharmaceutical composition and use |
| 06/24/2008 | US7390908 Such as 2-[3,5-Di(2-chlorobenzyloxy)benzoyl)amino]-thiazole; for treatment of diabetes |
| 06/24/2008 | US7390907 Vanilloid receptor ligands and their use in treatments |
| 06/24/2008 | US7390896 Preventing the deposits of amyloid protein, treating neurodegenerative disease, Alzheimer's disease and Down's Syndrome; {[carbamoyl]cycloalkyl}-N-(2-oxo-5-phenyl((S)-3H-benzo[f]1,4-diazepin-3-yl))- or (2-oxo-5-phenyl((S)-3H-benzo[f]1,4-diazepin-3-yl))-carboxamide |
| 06/24/2008 | US7390890 1,4-Dideoxy-1-C-(4-hydroxypyrrolo[3,2-d]pyrimidin-7-yl)-1,4-imino-D-ribitol derivatives or salts; parasite purine nucleoside, -hydrolase, -phosphorylase and/or phosphoribosyl transferase inhibitors; antiprotozoa, anticarcinogenic, antiinflammatory, and immunosuppressant agents; autoimmune diseases |
| 06/24/2008 | US7390827 Herbicides for selectively controlling broadleaf and gramineous weeds in crops of useful plants, especially in rice crops |
| 06/24/2008 | US7390815 Pyrazole compounds useful as protein kinase inhibitors |
| 06/24/2008 | US7390810 Pyrazole-amine compounds useful as kinase inhibitors |
| 06/24/2008 | US7390804 formula (I) has an inhibitory activity against cysteine protease and therefore it is useful as an agent for the prophylaxis and/or treatment of inflammatory diseases, diseases induced by apoptosis, diseases induced by disorders of immune responses, autoimmune diseases, diseases induced by decomposition |
| 06/24/2008 | US7390799 N-acylsulfonamides; BCL-X1 protein inhibitors; anticarcinogenic agents; bladder cancer; N-(4-(4-((2-(4-chlorophenyl)-5,5-dimethyl-1-cyclohex-1-en-1-yl)methyl)piperazin-1-yl)benzoyl)-4-(((1R)-3-(morpholin-4-yl)-1-((phenylsulfanyl)methyl)propyl)amino)-3-((trifluoromethyl)sulfonyl)benzenesulfonamide |
| 06/24/2008 | US7390790 Antilipemic agents; anticholesterol agents, for example, 2,3,4,5,6-Pentahydroxyhexylamide of 4-(4-{4-[3-[3-(4-fluorophenyl)-3-hydroxypropyl]-2-(4-methoxyphenyl)-4-oxoazetidin-1-yl]benzylcarbamoyl}phenoxy)benzoic acid |
| 06/19/2008 | WO2008073480A1 Compounds and compositions as kinase inhibitors |
| 06/19/2008 | WO2008073461A2 Ion channel modulators |
| 06/19/2008 | WO2008073305A1 6-oxo.-1, 6-dihydropyrimidin-2-yls in the treatment of proliferative diseases |
| 06/19/2008 | WO2008072257A2 Process for the preparation of indole derivatives |
| 06/19/2008 | WO2008072053A2 Substituted arylpyrazoles |
| 06/19/2008 | WO2008071646A1 New pyridazine derivatives with mch antagonistic activity and medicaments comprising these compounds |
| 06/19/2008 | WO2008071453A1 1,2-diarylacetylene derivatives of acyltryptophanols |
| 06/19/2008 | WO2008049123A3 2,4-pyrimidinediamine derivatives as inhibitors of jak kinases for the treatment of autoimmune diseases |
| 06/19/2008 | WO2008043544A8 Sulfonamide substituted pyrazoline compounds, their preparation and use as cb1 modulators |
| 06/19/2008 | US20080146818 Dipeptidylpeptidase IV (DPP-IV) inhibitory activity; (2S,4S)-1-[[N-(4-ethoxycarbonylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile)); diabetes |
| 06/19/2008 | US20080146808 Antiapoptosis; cancers; inhibiting the caspases; |
| 06/19/2008 | US20080146632 Fc Receptor Modulating Compounds and Compositions |
| 06/19/2008 | US20080146627 Thiazole, oxazole, imidazole, isoxazole and isoxazoline derivatives, e.g., butyl 2-(4-[1,1'-biphenyl]-4-yl-1H-imidazol-2-yl)ethylcarbamate inhibit lipidic peroxidation and monoamine oxidase and modulate sodium channels and are used for treating neurodegenerative disorders or pain. |
| 06/19/2008 | US20080146599 receptor tyrosine kinase inhibitors such as 2-chloro-N-{3-[(4,6-diaminopyrimidin-5-yl)ethynyl]phenyl}benzenesulfonamide, used as angiogenesis inhibitors in mammals |
| 06/19/2008 | US20080146587 for enhancing cognitive memory in an Alzheimer's patient; 5-HT2-selective and 5-HT6 selective ligands |
| 06/19/2008 | US20080146578 Indolylmaleimide derivatives |
| 06/19/2008 | US20080146575 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one as crystalline; enzyme poly(ADP-ribose)polymerase (synthase)-1 or poly ADP-ribosyltransferase (PARP-1) inhibitor; anticarcinogenic with BRCA2 deficient phenotype; septic shock, ischemic injury, multiple sclerosis |
| 06/19/2008 | US20080146574 Heterocycle Substituted Carboxylic Acids |